Self-Regulatory Organizations; The Nasdaq Stock Market LLC; Notice of Filing of Proposed
Rule Change to Modify the Application of the Minimum Bid Price Compliance Periods and the
Delisting Appeals Process for Bid Price Non-Compliance in Listing Rules 5810 and 5815 Under
Certain Circumstances
[Release No. 34-100767; File No. SR-NASDAQ-2024-045]
|
|
| Jan. 8, 2025 | Arnold Golub,
Vice President, Listing Qualifications, Deputy General Counsel, Nasdaq, Inc. |
| Dec. 31, 2024 | Taft Stettinius & Hollister LLP |
| Nov. 23, 2024 | Kassim Altawil |
| Nov. 23, 2024 | Alexey Nikolaev |
| Nov. 20, 2024 | Faith L. Charles, Thompson Hine LLP |
| Nov. 14, 2024 | Seth Lederman, Tonix Pharmaceuticals Holding Corp. |
| Nov. 5, 2024 | Arnold Golub, Vice President, Deputy General Counsel, Nasdaq Stock Market LLC |
| Oct. 8, 2024 | Ellen Greene, Managing Director, Equities & Options Market Structure, Securities Industry and Financial Markets Association and Joseph Corcoran, Managing Director and Associate General Counsel, Securities Industry and Financial Markets Association |
| Sep. 17, 2024 | Daniel Zinn, General Counsel, OTC Markets Group Inc. and Flavia Vehbiu, Deputy General Counsel, OTC Markets Group Inc. |
| Sep. 13, 2024 | American Consumer and Investor Institute |
| Sep. 10, 2024 | Anonymous |
| Aug. 28, 2024 | Jennifer Becker, Augusta Township, Michigan |
| Aug. 23, 2024 | Joseph Saluzzi, Partner, Themis Trading LLC; John Ramsay, Chief Market Policy Officer, Investors Exchange LLC; Stephen Hall, Legal Director, Better Markets; Christopher A. Iacovella, President and Chief Executive Officer, American Securities Association; Tyler Gellasch, President and CEO, Healthy Markets Association |
Meetings with SEC Officials
(Click here for submitted comments from the public)
|
| Oct. 23, 2024 | Memorandum from the Office of Market Supervision, Division of Trading and Markets regarding an October 21, 2024, meeting with representatives of OTC Markets Group Inc. |
